Is Frontiers in Immunology a Good Journal? An Honest Assessment for 2026

Frontiers in Immunology is one of the highest-volume immunology journals in the world, publishing tens of thousands of articles per year. It has an impact factor of 5.9 and an acceptance rate around 40%. It's legitimate, indexed, and widely cited, but it's also a journal where volume is part of the business model.

The Short Answer

Frontiers in Immunology is a legitimate, mid-tier immunology journal. It's fine for technically sound work, review articles, and building a publication record. It's not where you send your best work if you're competing for selective journals like Immunity or Nature Immunology.

The Numbers

What the Volume Tells You

A journal publishing 15,000+ articles per year can't be highly selective. For context, Immunity publishes around 200 papers per year. Nature Immunology publishes around 150. The review process at Frontiers checks for scientific soundness, not for novelty or significance.

This isn't necessarily bad. It means technically correct work with valid methodology gets published, even if the finding isn't groundbreaking. But it does mean a Frontiers in Immunology publication carries less prestige than a selective journal.

The Collaborative Review Model

Frontiers uses a distinctive peer review approach. Instead of anonymous reviewers sending reports to the editor, reviewers and authors interact directly during review. The process works like this:

1. Independent review. Reviewers evaluate the manuscript and submit initial reports.
2. Interactive discussion. Authors respond to concerns, reviewers can ask follow-up questions, and the exchange continues until issues are resolved or the paper is rejected.
3. Acceptance threshold. If the reviewers are satisfied that the science is sound, the paper is accepted. The bar is methodological validity, not field-changing significance.

Some researchers appreciate this model as more constructive and less adversarial than traditional peer review. Others view it as less rigorous because the interaction creates pressure toward acceptance rather than rejection.

Frontiers in Immunology vs Selective Immunology Journals

The gap between Frontiers and the selective journals isn't just prestige. It reflects fundamentally different editorial philosophies. Immunity asks "does this change the field?" Frontiers asks "is this scientifically valid?"

When to Use Frontiers in Immunology

1. You need to publish quickly. Frontiers' review process is generally fast (2-3 months) and the collaborative model means fewer rounds of back-and-forth rejection.
2. Your work is solid but not top-tier competitive. Technically sound, valid methodology, but unlikely to get into Immunity or Nature Immunology.
3. You're writing a review article. Frontiers publishes many reviews, and well-written reviews in Frontiers get cited heavily. Some of the journal's most-cited papers are reviews.
4. Your grant requires an open-access publication with a reasonable APC.
5. You're early-career and building a publication record. A Frontiers paper counts on your CV and in PubMed.
6. Systematic reviews and meta-analyses. Frontiers is receptive to these, and they fill an important gap in the immunology literature.

When NOT to Use It

1. You have career-defining work. Submit to Immunity, Nature Immunology, or JEM first. You can always come to Frontiers later if they reject you.
2. Your tenure or promotion committee cares about journal selectivity. Some committees look at acceptance rates as a proxy for rigor. A 40% acceptance rate may raise questions.
3. You want the prestige of rigorous peer review. For grant applications and career milestones, a publication in a selective journal carries more weight than five Frontiers papers.
4. Your institution or collaborators view Frontiers negatively. Fairly or not, some researchers have concerns about the Frontiers business model. Know your audience.

The Business Model Question

Frontiers is a for-profit publisher. Its revenue comes from APCs ($2,950 per article). Publishing 15,000+ articles per year at that rate generates substantial revenue. Critics argue this creates an incentive to accept rather than reject. Frontiers disputes this, pointing to their editorial standards and collaborative review model.

You should be aware of this debate. For most practical purposes, Frontiers in Immunology is a legitimate journal that publishes valid science. But if you're at an institution or in a country where Frontiers carries stigma, factor that into your decision.

Practical Submission Tips

1. Choose the right specialty section. Frontiers in Immunology has dozens of sections (Autoimmunity, Cancer Immunity, Mucosal Immunity, etc.). Selecting the right one determines which editors handle your paper.
2. Budget for the APC. $2,950 isn't trivial. Make sure your grant or institution will cover it before submission.
3. Prepare for interactive review. You'll communicate directly with reviewers. Be professional, responsive, and thorough.
4. Review articles can be valuable here. If you have expertise in an area and want to write an in-depth review, Frontiers is a good venue. Well-cited reviews build your reputation.
5. Consider Research Topics. Frontiers organizes themed collections (Research Topics) with guest editors. Contributing to one can increase visibility.

More Resources

• Frontiers in Immunology journal guide
• Immunology journals by field
• Acceptance rates across 50+ journals
• Review timelines compared